4-Oxo-3,4-dihydro-phthalazine-1-carboxylic acid, 95.0%, 100mg

5-Formylnicotinonitrile, 95.0%, 25g

5-Chloro-2-(trifluoromethyl)phenylacetonitrile, 95.0%, 10g

(4S,4'S)-4,4'-BIS(1,1-DIMETHYLETHYL)-4,4',5,5'-TETRAHYDRO-2,2'-BIOXAZOLE, 95%, 250mg

GC capillary column ROTI®Cap-1, 30 m, 0.32 mm, 0.35 µm, 1 Piece(s)

2,2,8,8-Tetramethyl-3,7-dioxa-2,8-disilanonane, 98.0%, 25g

4-Hydroxy-3-nitrobenzoic Acid>98.0%(HPLC)(T)25g

4-[2-(4-Methyl-1-piperidinyl)-2-oxoethoxy]benzaldehyde, 95.0%, 1g

(R)-3-(5-Bromo-1-oxoisoindolin-2-yl)piperidine-2,6-dione, 98%, 1g

(3-Bromo-6-methylpyridin-2-yl)methanol, 97%, 5g

1-Fluoro-4-(prop-2-yn-1-yloxy)benzene, 95%, 250mg

6-O-tert-butyl 2-O-ethyl 4,5,7,8-tetrahydro-[1,3]thiazolo[4,5-d]azepine-2,6-dicarboxylate, 95+%, 250mg

2-(Trifluoromethyl)-9H-thioxanthen-9-one, 97.0%, 100g